Selected article for: "bias moderate risk and low risk"
Author: Stokes, Katy; Peltrini, Roberto; Bracale, Umberto; Trombetta, Marcella; Pecchia, Leandro; Basoli, Francesco
Title: Enhanced Medical and Community Face Masks with Antimicrobial Properties: A Systematic Review
  • Cord-id: 6w7ugp82
  • Document date: 2021_9_9
    • ID: 6w7ugp82
    Snippet: Face masks help to limit transmission of infectious diseases entering through the nose and mouth. Beyond reprocessing and decontamination, antimicrobial treatments could extend the lifetime of face masks whilst also further reducing the chance of disease transmission. Here, we review the efficacy of treatments pertaining antimicrobial properties to medical face masks, filtering facepiece respirators and non-medical face masks. Searching databases identified 2113 studies after de-duplication. A t
    Document: Face masks help to limit transmission of infectious diseases entering through the nose and mouth. Beyond reprocessing and decontamination, antimicrobial treatments could extend the lifetime of face masks whilst also further reducing the chance of disease transmission. Here, we review the efficacy of treatments pertaining antimicrobial properties to medical face masks, filtering facepiece respirators and non-medical face masks. Searching databases identified 2113 studies after de-duplication. A total of 17 relevant studies were included in the qualitative synthesis. Risk of bias was found to be moderate or low in all cases. Sixteen articles demonstrated success in avoiding proliferation (if not elimination) of viruses and/or bacteria. In terms of methodology, no two articles employed identical approaches to efficacy testing. Our findings highlight that antimicrobial treatment is a promising route to extending the life and improving the safety of face masks. In order to reach significant achievements, shared and precise methodology and reporting is needed.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory syndrome and low cost approach: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome and low moderate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lower drop: 1
    • acute respiratory syndrome and lrv reduction value: 1
    • acute respiratory syndrome coronavirus and low cost approach: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory syndrome coronavirus and low moderate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and lower drop: 1
    • acute respiratory syndrome coronavirus and lrv reduction value: 1
    • log reduction and low moderate: 1
    • log reduction and lrv reduction value: 1
    • long term storage and low risk consider: 1